Publication Results (160)

• «
• 1
• 2
• 3
• 4
• »

• Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders

  Tinmouth J, Patel J, Austin PC, Baxter NN, Brouwers MC, Earle C, Levitt C, Lu Y, Mackinnon M, Paszat L, Rabeneck L.Int J Cancer. 2015; 136(6):e697-703. Epub 2014 Sep 23.

• Utilization and costs of home care for patients with colorectal cancer: a population-based study

  Mittmann N, Liu N, Porter J, Seung SJ, Isogai PK, Saskin R, Cheung MC, Leighl NB, Hoch JS, Trudeau M, Evans WK, Dainty KN, Earle CC. CMAJ Open. 2014; 2(1):E11-17. Epub 2014 Feb 4.

• A simplified, oninvasive stool DNA test for colorectal cancer detection

  Itzkowitz S, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, Schroy PC 3rd, Sontag S, Johnson D, Markowitz S, Paszat L, Berger BM. Am J Gastroenterol. 2008; 103(11):2862-70. Epub 2008 Aug 27.

• Surveillance patterns after curative-intent colorectal cancer surgery in Ontario

  Tan J, Muir J, Coburn N, Singh S, Hodgson D, Saskin R, Kiss A, Paszat L, El-Sedfy A, Grunfeld E, Earle C, Law C. Can J Gastroenterol Hepatol. 2014; 28(8):427-33. Epub 2014 Jul 11.

• Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005–2011

  Honein-AbouHaidar GN, Baxter NN, Moineddin R, Urbach DR, Rabeneck L, Bierman AS. Cancer Epidemiol. 2013; 37(6):946-56. Epub 2013 May 20.

• Cost-effectiveness of first-line treatments for patients with KRAS wild-type metastatic colorectal cancer

  Ewara EM, Zaric GS, Welch S, Sarma S. Curr Oncol. 2014; 21(4):e541-50.

• Using physician-linked mailed invitations in an organised colorectal cancer screening programme: effectiveness and factors associated with response

  Tinmouth J, Baxter NN, Paszat LF, Rabeneck L, Sutradhar R, Yun L. BMJ Open. 2014; 4(3):e004494. Epub 2014 Mar 12.

• Long-term survival in young adults with colorectal cancer: a population-based study

  Forbes SS, Sutradhar R, Paszat LF, Rabeneck L, Urbach DR, Baxter NN. Dis Colon Rectum. 2010; 53(7):973-8.

• Association between subject factors and colorectal cancer screening participation in Ontario, Canada

  Ramji F, Cotterchio M, Manno M, Rabeneck L, Gallinger S. Cancer Detect Prev. 2005; 29(3):221-6.

• Uptake of colorectal cancer screening among Ontarians with intellectual and developmental disabilities

  Ouellette-Kuntz H, Coo H, Cobigo V, Wilton AS. PLoS One. 2015; 10(2):e0118023.

• Repeated faecal occult blood testing is associated with decreased advanced colorectal cancer risk: a population-based study

  James PD, Rabeneck L, Yun L, Paszat L, Baxter NN, Govindarajan A, Antonova L, Tinmouth JM. J Med Screen. 2017; 25(3):141-8. Epub 2017 Sep 1.

• Temporal trends in new diagnoses of colorectal cancer with obstruction, perforation, or emergency admission in Ontario: 1993-2001

  Rabeneck L, Paszat LF, Rothwell DM, He J. Am J Gastroenterol. 2005; 100(3):672-6.

• Uptake of colorectal cancer screening by physicians is associated with greater uptake by their patients

  Litwin O, Sontrop JM, McArthur E, Tinmouth J, Rabeneck L, Vinden C, Sood MM, Baxter NN, Tanuseputro, Welk B, Garg AX. Gastroenterology. 2020; 158(4):905-14. Epub 2019 Nov 1. DOI: https://doi.org/10.1053/j.gastro.2019.10.027

• A population-based study of the extent of colorectal cancer screening in men with HIV

  Antoniou T, Jembere N, Saskin R, Kopp A, Glazier RH. BMC Health Serv Res. 2015; 15(1):51. Epub 2015 Feb 1.

• Colorectal cancer survival in multiple sclerosis: a matched cohort study

  Marrie RA, Maxwell C, Mahar A, Ekuma O, McClintock C, Seitz D, Groome P. Neurology. 2021; 97(14):e1447-56. Epub 2021 Sep 15. DOI: https://doi.org/10.1212/WNL.0000000000012634

• Incidence of diabetes in colorectal cancer survivors

  Singh S, Earle CC, Bae SJ, Fischer HD, Yun L, Austin PC, Rochon PA, Anderson GM, Lipscombe L. J Natl Cancer Inst. 2016; 108(6):djv402. Epub 2016 Feb 2.

• Outcomes in elderly patients following surgery for colorectal cancer in the veterans affairs health care system

  Rabeneck L, Davila J, Thompson M, El-Serag HB. Aliment Pharmacol Ther. 2004; 20(10):1115-24.

• Survival after hepatic resection of colorectal cancer metastases: a national experience

  Robertson DJ, Stukel TA, Gottlieb DJ, Sutherland JM, Fisher ES. Cancer. 2009; 115(4):752-9.

• Colonic stents for colorectal cancer are seldom used and mainly for palliation of obstruction: a population-based study

  Borowiec AM, Wang CSK, Yong E, Law C, Coburn N, Sutradhar R, Baxter N, Paszat L, Tinmouth J. Can J Gastroenterol Hepatol. 2016; 2016:1945172. Epub 2016 Mar 29.

• Risk of colorectal cancer among immigrants to Ontario, Canada

  Paszat L, Sutradhar R, Liu Y, Baxter NN, Tinmouth J, Rabeneck L. BMC Gastroenterol. 2017; 17(1):85.

• Incidence of breast and colorectal cancer among immigrants in Ontario, Canada: a retrospective cohort study from 2004-2014

  Shuldiner J, Liu Y, Lofters A. BMC Cancer. 2018; 18:537. Epub 2018 May 8.

• Outcomes of resected colorectal cancer lung metastases in routine clinical practice: a population-based study

  Booth CM, Nanji S, Wei X, Mackillop WJ. Ann Surg Oncol. 2016; 23(4):1057-63. Epub 2015 Nov 16.

• Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening in Ontario, Canada--a replication study

  Ritvo P, Myers R, Del Giudice ML, Pazsat L, Campbell PT, Howlett RI, Mai V, Sullivan T, Tiro J, Rabeneck L. Cancer Epidemiol Biomarkers Prev. 2008; 17(11):3279-83.

• Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study

  Lakoff J, Paszat LF, Saskin R, Rabeneck L. Clin Gastroenterol Hepatol. 2008; 6(10):1117-21. Epub 2008 Aug 8.

• Rates of new or missed colorectal cancer after barium enema and their risk factors: a population-based study

  Toma J, Paszat LF, Gunraj N, Rabeneck L. Am J Gastroenterol. 2008; 103(12):3142-8. Epub 2008 Oct 1.

• Interval colorectal cancers following guaiac fecal occult blood testing in the Ontario ColonCancerCheck program

  Paszat L, Sutradhar R, Tinmouth J, Baxter N, Rabeneck L. Can J Gastroenterol Hepatol. 2016; 2016:4768728. Epub 2016 May 8.

• Outcomes after repeat hepatic resection for recurrent metastatic colorectal cancer: a population-based study

  Nanji S, Tsang ME, Wei X, Booth CM. Am J Surg. 2017; 213(6):1053-9. Epub 2016 Sep 6.

• Effect of colonoscopy on colorectal cancer incidence and mortality: an instrumental variable analysis

  Jacob BJ, Moineddin R, Sutradhar R, Baxter NN, Urbach DR. Gastrointest Endosc. 2012; 76(2):355-64. Epub 2012 Jun 4.

• Surgery for diverticular disease results in a higher hernia rate compared to colorectal cancer: a population-based study from Ontario, Canada

  Tang ES, Robertson DI, Whitehead M, Xu J, Hall SF. Hernia. 2018; 22(4):603-9. Epub 2017 Nov 16.

• Colonoscopy resource availability and its association with the colorectal cancer diagnostic interval: a population-based cross-sectional study

  Webber C, Flemming JA, Birtwhistle R, Rosenberg M, Groome PA. Eur J Cancer Care (Engl). 2020; 29(1):e13187. Epub 2019 Nov 10. DOI: https://doi.org/10.1111/ecc.13187

• Colorectal cancer screening with nurse-performed flexible sigmoidoscopy: results from a Canadian community-based program

  Shapero TF, Hoover J, Paszat LF, Burgis E, Hsieh E, Rothwell DM, Rabeneck L. Gastrointest Endosc. 2007; 65(4):640-5. Epub 2006 Dec 14.

• Real-world colorectal cancer diagnostic pathways in Ontario, Canada: a population-based study

  Guan Z, Webber C, Flemming JA, Mavor ME, Whitehead M, Chen BE, Groome PA. Eur J Cancer Care (Engl). 2022; e13603. Epub 2022 May 3. DOI: https://doi.org/10.1111/ecc.13603

• Association between colonoscopy rates and colorectal cancer mortality

  Rabeneck L, Paszat LF, Saskin R, Stukel TA. Am J Gastroenterol. 2010; 105(7):1627-32. Epub 2010 Mar 2.

• Association of colonoscopy and death from colorectal cancer

  Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Ann Intern Med. 2009; 150(1):1-8. Epub 2008 Dec 15.

• Surgical volume and long-term survival following surgery for colorectal cancer in the Veterans Affairs Health-Care System

  Rabeneck L, Davila JA, Thompson M, El-Serag HB. Am J Gastroenterol. 2004; 99(4):668-75.

• Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis

  Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Gastroenterology. 2007; 132(1):96-102.

• Pulmonary metastasectomy for colorectal cancer: predictors of survival in routine surgical practice

  Nanji S, Karim S, Tang E, Brennan K, McGuire A, Pramesh CS, Booth CM. Ann Thorac Surg. 2018; 105(6):1605-12. Epub 2018 Mar 5.

• Risk of colorectal cancer after a negative colonoscopy in low-to-moderate risk individuals: impact of a 10-year colonoscopy

  Murthy SK, Dubé C, Rostom A, Benchimol EI, Ducharme R, Sutradhar R, Rabeneck L, Paszat L, Tinmouth J. Endoscopy. 2017; 49(12):1229-36. Epub 2017 Sep 15.

• Decreased colorectal cancer incidence and incidence-based mortality in the screening-age population of Ontario

  Paszat LF, Sutradhar R, Corn E, Tinmouth J, Baxter NN, Rabeneck L. J Can Assoc Gastroenterol. 2021; 4(3):146–55. Epub 2020 Oct 15. DOI: https://doi.org/10.1093/jcag/gwaa035

• Stage of colorectal cancer diagnosis for immigrants: a population-based retrospective cohort study in Ontario, Canada

  Lofters AK, Gatov E, Lu H, Baxter NN, Corrado AM, Guilcher SJT, Kopp A, Vahabi M, Datta GD. Cancer Causes Control. 2021; 32(12):1433-46. Epub 2021 Aug 31. DOI: https://doi.org/10.1007/s10552-021-01491-5

• «
• 1
• 2
• 3
• 4
• »